Transcranial Direct Current Stimulation for Treating Parkinson´s Disease-related Pain in OFF State

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

July 1, 2023

Primary Completion Date

March 15, 2024

Study Completion Date

April 11, 2024

Conditions
Parkinson DiseasePain
Interventions
DEVICE

Active Transcranial Direct Current Stimulation

The Starstim tCS® equipment will be used, with 35 cm2 sponge electrodes. The tDCS over M1 will be performed by placing the active anode on the C3 point (10/20 EEG system) and the cathode on the contralateral supraorbital area (Fp2). Regarding the stimulated hemisphere, in cases of asymmetric pain, it will be applied to the contralateral M1, and in cases of bilateral pain, it will be applied to the M1 of the dominant hemisphere. A constant current of 2 mA (subthreshold intensity) will be applied for 20 minutes, with the first 30 seconds used as a ramp-up and the last 30 seconds as a ramp-down. Number of sessions: 1.

DEVICE

Sham Transcranial Direct Current Stimulation

The Starstim tCS® equipment (Neuroelectrics Inc, Barcelona, Spain) will be used with 35 cm2 sponge electrodes. The tDCS sham over M1 will be performed by placing the electrodes in the same position as in the active tDCS protocol. However, the stimulator will automatically turn off after 30 seconds of stimulation, making it a reliable sham stimulation method. Therefore, subjects will feel the same tingling sensation but will not receive current for the remainder of the stimulation time.

DRUG

Dopaminergic medication

After tDCS, the participant will take their regular dopaminergic medication in order to go from OFF state to ON state.

Trial Locations (1)

28007

Hospital Beata Maria Ana, Madrid

All Listed Sponsors
collaborator

Universidad Rey Juan Carlos

OTHER

collaborator

Hospital Beata María Ana

OTHER

lead

Universidad Francisco de Vitoria

OTHER